Paper Details
- Home
- Paper Details
Effect of raloxifene after recombinant teriparatide [hPTH(1-34)] treatment in postmenopausal women with osteoporosis.
Author: AdamiS, BrandiM L, BrownJ P, DalskyG P, EconsM J, FelsenbergD, McClungM, Muñoz-TorresM, San MartinJ, SiposA, XieL
Original Abstract of the Article :
Loss of bone mineral density occurs after discontinuation of teriparatide, if no subsequent treatment is given. Sequential raloxifene prevented rapid bone loss at lumbar spine and further increased bone mineral density (BMD) at femoral neck, whether raloxifene was started immediately or after a one-...See full text at original site
Dr.Camel's Paper Summary Blogラクダ博士について
ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。
* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。
引用元:
https://doi.org/10.1007/s00198-007-0485-y
データ提供:米国国立医学図書館(NLM)
Bone Health: Raloxifene and Teriparatide, a Winning Combination?
Osteoporosis, a condition characterized by weakened bones, is a common concern, particularly among postmenopausal women. Like a camel traversing a treacherous desert landscape, bones can become brittle and prone to fractures. This study examines the effectiveness of raloxifene, a medication used to treat osteoporosis, following treatment with teriparatide, a bone-building hormone. Researchers followed a group of postmenopausal women with osteoporosis, investigating whether raloxifene could help maintain bone density after teriparatide treatment. Their findings offer valuable insights into the potential of sequential therapy for optimizing bone health.A Collaborative Effort for Strong Bones
The study demonstrates that raloxifene, administered after teriparatide treatment, can effectively prevent bone loss and even enhance bone density in postmenopausal women with osteoporosis. This sequential approach offers a promising strategy for maintaining bone strength and reducing the risk of fractures. The study's findings highlight the importance of tailoring treatment strategies to individual needs, as the timing of raloxifene initiation can significantly influence its effectiveness.Maintaining Bone Health: A Journey Through Time
This study provides valuable insights into the importance of a comprehensive approach to managing osteoporosis. While raloxifene and teriparatide have shown promise in this study, it's essential to remember that individual needs vary. Consulting with a healthcare professional to develop a personalized treatment plan based on your specific medical history and risk factors is crucial for maintaining optimal bone health.Dr. Camel's Conclusion
This study demonstrates the potential benefits of sequential therapy with raloxifene and teriparatide for managing osteoporosis in postmenopausal women. The findings suggest that this combined approach can help maintain bone density and reduce the risk of fractures. Remember, just as a camel needs to adapt to the changing desert landscape, our bone health requires a dynamic approach that considers our individual needs and circumstances.Date :
- Date Completed 2008-07-18
- Date Revised 2021-10-20
Further Info :
Related Literature
Article Analysis
SNS
PICO Info
in preparation
Languages
English
Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.
This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.